Abstract
Most cytotoxic chemotherapy protocols used in small animals are designed to have a low risk of adverse effects; however, adverse events can occasionally occur. Timely and appropriate management of adverse events greatly increases client satisfaction and the likelihood of a successful treatment outcome. This article presents guidelines for the management of chemotherapy-associated hematological and gastrointestinal disturbances, extravasation injury, and anaphylaxis.
MeSH terms
-
Anaphylaxis / chemically induced
-
Anaphylaxis / prevention & control
-
Anaphylaxis / veterinary
-
Animals
-
Antineoplastic Agents / adverse effects*
-
Cat Diseases / chemically induced*
-
Cat Diseases / prevention & control
-
Cat Diseases / therapy*
-
Cats
-
Dog Diseases / chemically induced*
-
Dog Diseases / prevention & control
-
Dog Diseases / therapy*
-
Dogs
-
Drug-Related Side Effects and Adverse Reactions / genetics
-
Drug-Related Side Effects and Adverse Reactions / veterinary
-
Female
-
Gastrointestinal Diseases / chemically induced
-
Gastrointestinal Diseases / therapy
-
Gastrointestinal Diseases / veterinary
-
Male
-
Necrosis / chemically induced
-
Necrosis / prevention & control
-
Necrosis / veterinary
-
Neoplasms / drug therapy
-
Neoplasms / veterinary*
-
Neutropenia / chemically induced
-
Neutropenia / drug therapy
-
Neutropenia / veterinary
-
Practice Guidelines as Topic
-
Sepsis / chemically induced
-
Sepsis / drug therapy
-
Sepsis / veterinary